Complete Remission in Metastatic Pancreatic Cancer: Nesuparib Shows Early Clinical Promise
Early clinical data point to extended survival and the rare possibility of complete remission in metastatic pancreatic cancer, a malignancy...
Search results for "subsidiary"
Ebola spreads rapidly in DRC—how far have new vaccines and treatments come?
A Reuters report said the U.K. media outlet The Guardian reported on the 19th (20th in Korea time) that the World Health Organization is considering...
Daewoong Pharmaceutical Acquires U.S. Cellular Reprogramming Tech to Fast-Track Anti-Aging Therapeutics
Daewoong Pharmaceutical is accelerating its research and development into anti-aging therapeutics.
Celltrion to Acquire French Healthcare Specialist Gifrer, Eyeing European Pharmacy Market
Celltrion announced on the 12th its acquisition of Gifrer, a French healthcare specialist with a 114-year history.
SCL Group and Hanaro Medical Foundation Bring K-Health to Indonesia’s National Central Hospital
Comprehensive healthcare solutions company SCL Group announced on the 28th that it signed a memorandum of understanding...
SCL Group and Hanaro Medical Foundation Accelerate K-Healthcare Expansion into Indonesia
SCL Group, a comprehensive healthcare solutions company led by Chairman Lee Kyung-ryul, is set to establish a strategic...
K-Pharma Sets Sights on Veterinary Market: Daewoong Pharmaceutical Leads the Charge
More than 10 South Korean pharmaceutical companies are pivoting toward veterinary medicine as a strategic growth engine.
YuhanUSA and Huinno Partner to Launch AI-Powered ECG Monitoring in the U.S.
YuhanUSA, the U.S. subsidiary of Yuhan Corporation, announced on the 30th that it has signed a strategic business...
ABL Bio to Present Two Bispecific Antibody ADC Posters at AACR
ABL Bio announced on the 19th that it will participate in this year’s American Association for Cancer Research Annual...
Celltrion: “Zymfentra prescriptions surging in the U.S.… growth is accelerating in earnest”
Celltrion’s subcutaneous formulation for autoimmune diseases, “Zymfentra,” which launched in the United States, has...